Psychiatria Polska
April 30, 2026
Bronisław Gębik, Katarzyna Bliźniewska-Kowalska, Piotr Gałecki
Od 2000 roku ketamina i jej enancjomery są badane pod kątem swojego działania przeciwdepresyjnego. W niniejszej pracy zostanie krótko podsumowana droga ketaminy od anestetyku do leku przeciwdepresyjnego. W tekście przedstawione zostaną najważniejsze mechanizmy jej działania a także działania jej metabolitów. Praca ta ma na celu opisać rolę konkretnych grup receptorów w aktywacji istotnych...
Psychiatria Polska
October 31, 2025
Katarzyna Kała, Katarzyna Sułkowska‐ziaja, Joanna Piotrowska et al.
Mushrooms of the Amanita genus are considered among the most toxic, causing severe poisoning, often resulting in death. However, of the 707 described species within this genus, only around a dozen contain the toxic octapeptides classified as amanitotoxins and phallotoxins. While most representatives of the genus are considered inedible species, there are a few exceptions that are palatable...
Psychiatria Polska
June 30, 2024
Piotr Gałecki, Katarzyna Maria Bliźniewska-Kowalska, Wiesław Jerzy Cubała et al.
5 citations
The Polish standard of treatment with racemic ketamine for patients with depressive disorders was developed by a Working Group appointed by the National Consultant in the field of psychiatry. Despite the wide range of available medications, as many as one-third of depressed patients do not respond to standard antidepressant treatment, raising the need for an ongoing search for new effective and...
Psychiatria Polska
June 30, 2024
Janusz Rybakowski, Filip Rybakowski
Consciousness is most frequently defined as a subjective experience of mental processes. The phenomenon of consciousness has always been a subject of great interest in various fields of science, including psychiatry, and the most prominent scientists have engaged in research on it. The studies performed in recent years have brought about novel data on the evolutionary and neurobiological...
Psychiatria Polska
June 30, 2023
Askaniusz Jachimowski, Krzysztof Kucia
Substances that change the states of consciousness have been used in the therapeutics of traditional cultures for hundreds of years. In the Western cultural circle, scientific curiosity and hope for a breakthrough in the treatment of various mental disorders constituted the basis of the first wave of research on humans with the use of psychedelics. After synthesizing LSD, psychedelic substances...
Psychiatria Polska
October 31, 2022
Gniewko Więckiewicz, Dariusz Danel, Magdalena Piegza et al.
2 citations
MDMA is one of the most commonly used drugs in the world. Clinical studies are currently being conducted around the world on the use of this substance in the treatment of PTSD and alcoholism. However, little demographic information is available on users who use the substance for recreational purposes. The aim was to determine basic demographic and helath characteristics with validated tools....
Psychiatria Polska
August 31, 2022
Sandra Szafoni, Gniewko Więckiewicz, Robert Pudło et al.
9 citations
Post-traumatic stress disorder (PTSD) is a common mental health condition that begins after exposure to a traumatic event. Despite recommended various therapeutic approaches, including both pharmacotherapy and psychotherapy, treatment is not as effective as expected. Over recent years the pharmaceutical industry has not been able to offer a new approach, founded on multiple mechanisms of...
Psychiatria Polska
April 30, 2020
Aleksandra Barabasz-Gembczyk, Krzysztof Kucia
4 citations
Ayahuaska, zwana również „lianą duszy”, „pnączem duszy” to rytualny psychodelik podawany tradycyjnie w formie wywaru roślinnego, od stuleci stosowany przez rdzenną ludność Ameryki Południowej, a w ostatnich 25 latach również w krajach Europy, Azji, Afryki, Australii, w Kanadzie i Stanach Zjednoczonych Ameryki Północnej. Jej aktywność biologiczna wynika z zawartości N,N- dimetrylotryptaminy...